Importantly, experiments conducted in HepG2 (hepatoblastoma) and HeLa (cervical cancer) cells – both carrying wild-type p53 – showed strong increases in caspase-3/7 activation following combined treatment with lovastatin and docetaxel (Supplementary Figure 2). This evidence concerns the gene TP53 and cervical carcinoma.